The treatment landscape of metastatic kidney cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, James Larkin, FRCP, PhD, of The Royal Marsden, London, UK, provides an overview of the current unmet needs in the treatment of metastatic kidney cancer.

Year of Production:
Running Time:
Color/Sound:

2015
01:10
Color/Sound

Comments are closed.